Exponential Pharma Ventures

Exponential Pharma Ventures, a company focused on co-developing early-stage biomedical technologies through pharmaceutical partnerships, is seeking collaborators to advance Embera’s lead product EMB-001C into Phase 2a clinical trials. Following clinical proof of concept, pharmaceutical partners will have the option to license and commercialize the product.